Invega Sustenna Drug Interactions
Currently displaying 117 drugs known to have a major interaction with Invega Sustenna (paliperidone).
- 117 major drug interactions
- 507 moderate drug interactions
- 2 minor drug interactions
Major interactions with Invega Sustenna (paliperidone)
Note: Showing generic names only.
A
B
C
- cabergoline
- cabozantinib
- carbamazepine
- ceritinib
- chloramphenicol
- chloroquine
- cisapride
- citalopram
- clozapine
- codeine
- crizotinib
D
E
F
G
H
I
K
L
M
- meperidine
- mesoridazine
- methadone
- metoclopramide
- metrizamide
- mifepristone
- mobocertinib
- morphine
- morphine liposomal
- moxifloxacin
N
O
P
- pacritinib
- panobinostat
- papaverine
- pasireotide
- pentazocine
- pergolide
- phenytoin
- pimozide
- ponesimod
- pramipexole
- procainamide
- propoxyphene
Q
R
S
T
V
Z
Invega Sustenna alcohol/food interactions
There are 4 alcohol/food interactions with Invega Sustenna (paliperidone).
Invega Sustenna disease interactions
There are 16 disease interactions with Invega Sustenna (paliperidone) which include:
- dementia
- QT Prolongation
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- priapism
- weight gain
- depression
- hyperprolactinemia
- tardive dyskinesia
- antiemetic effect
- gastrointestinal obstruction
More about Invega Sustenna (paliperidone)
- Invega Sustenna consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (191)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.